Most sold healthcare stocks in Q4 2025
See which Healthcare stocks institutional investors trimmed or exited the most in Q4 2025, measured as net reductions in reported share positions from Q3 2025 into Q4 2025. Notable reductions at the top of this list include HALEON PLC-ADR (HLN), AVANTOR INC (AVTR), ELANCO ANIMAL HEALTH INC (ELAN), GSK PLC-SPON ADR (GSK). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| HLN | HALEON PLC-ADR | -158,972,342 | -$1.43B | 0 | 0 | 2 | 4 | 2 |
| AVTR | AVANTOR INC | -118,801,788 | -$1.51B | 0 | 2 | 1 | 3 | 3 |
| ELAN | ELANCO ANIMAL HEALTH INC | -82,780,607 | -$1.67B | 0 | 0 | 0 | 2 | 0 |
| GSK | GSK PLC-SPON ADR | -80,751,086 | -$3.48B | 0 | 1 | 3 | 3 | 5 |
| CVS | CVS HEALTH CORP | -73,905,895 | -$5.49B | 0 | 2 | 5 | 4 | 8 |
| SNY | SANOFI-ADR | -68,868,797 | -$3.25B | 0 | 2 | 0 | 2 | 2 |
| BAX | BAXTER INTERNATIONAL INC | -40,540,754 | -$1.22B | 0 | 3 | 1 | 3 | 5 |
| RXRX | RECURSION PHARMACEUTICALS-A | -33,545,499 | -$163.70M | 0 | 0 | 0 | 1 | 0 |
| GILD | GILEAD SCIENCES INC | -32,865,681 | -$3.61B | 0 | 0 | 3 | 2 | 4 |
| GEHC | GE HEALTHCARE TECHNOLOGY | -28,520,789 | -$2.14B | 0 | 0 | 1 | 4 | 2 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | -26,936,354 | -$32.13M | 2 | 0 | 0 | 1 | 2 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | -24,703,712 | -$2.44B | 0 | 2 | 3 | 6 | 5 |
| CERS | CERUS CORP | -19,191,688 | -$30.28M | 0 | 0 | 1 | 1 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | -17,547,298 | -$911.56M | 0 | 0 | 2 | 2 | 2 |
| INCY | INCYTE CORP | -15,489,561 | -$1.26B | 0 | 0 | 1 | 4 | 1 |
| HUM | HUMANA INC | -12,445,293 | -$3.27B | 0 | 1 | 3 | 2 | 4 |
| BSX | BOSTON SCIENTIFIC CORP | -12,371,138 | -$1.23B | 1 | 1 | 3 | 4 | 5 |
| ABSI | ABSCI CORP | -12,162,773 | -$36.97M | 0 | 0 | 0 | 1 | 0 |
| TXG | 10X GENOMICS INC-CLASS A | -11,381,778 | -$125.89M | 0 | 1 | 0 | 1 | 1 |
| NVS | NOVARTIS AG-SPONSORED ADR | -11,132,682 | -$1.41B | 1 | 1 | 3 | 2 | 5 |
| NTLA | INTELLIA THERAPEUTICS INC | -10,897,478 | -$202.05M | 0 | 1 | 0 | 1 | 1 |
| BEAM | BEAM THERAPEUTICS INC | -10,891,467 | -$263.80M | 1 | 0 | 0 | 2 | 1 |
| DHR | DANAHER CORP | -10,260,733 | -$1.81B | 0 | 1 | 4 | 8 | 6 |
| BDX | BECTON DICKINSON AND CO | -10,012,427 | -$1.87B | 1 | 0 | 1 | 3 | 4 |
| CI | THE CIGNA GROUP | -9,764,480 | -$2.82B | 0 | 2 | 1 | 3 | 3 |
| UNH | UNITEDHEALTH GROUP INC | -9,576,490 | -$3.90B | 1 | 3 | 10 | 9 | 15 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | -9,436,782 | -$190.62M | 0 | 0 | 0 | 5 | 0 |
| XRAY | DENTSPLY SIRONA INC | -8,931,584 | -$122.06M | 1 | 1 | 0 | 3 | 2 |
| SOLV | SOLVENTUM CORP | -8,318,495 | -$602.13M | 0 | 2 | 1 | 2 | 3 |
| PSNL | PERSONALIS INC | -8,219,535 | -$53.38M | 1 | 0 | 1 | 1 | 2 |
| QSI | QUANTUM-SI INC | -7,624,042 | -$10.75M | 0 | 0 | 0 | 1 | 0 |
| TEM | TEMPUS AI INC | -7,434,356 | -$604.41M | 1 | 0 | 2 | 1 | 3 |
| TWST | TWIST BIOSCIENCE CORP | -6,726,808 | -$189.29M | 0 | 0 | 0 | 1 | 0 |
| ELV | ELEVANCE HEALTH INC | -6,193,793 | -$2.02B | 0 | 1 | 6 | 4 | 7 |
| EVH | EVOLENT HEALTH INC - A | -5,799,412 | -$49.84M | 0 | 0 | 1 | 1 | 1 |
| NBIX | NEUROCRINE BIOSCIENCES INC | -5,740,505 | -$802.61M | 0 | 0 | 1 | 2 | 1 |
| BFLY | BUTTERFLY NETWORK INC | -5,672,377 | -$10.06M | 1 | 0 | 0 | 1 | 1 |
| PRME | PRIME MEDICINE INC | -5,463,362 | -$32.65M | 0 | 1 | 0 | 1 | 1 |
| ZTS | ZOETIS INC | -5,314,968 | -$887.24M | 0 | 3 | 2 | 7 | 5 |
| BMY | BRISTOL-MYERS SQUIBB CO | -5,284,651 | -$49.29M | 2 | 2 | 3 | 4 | 8 |
| REGN | REGENERON PHARMACEUTICALS | -5,026,587 | -$2.79B | 0 | 1 | 1 | 5 | 2 |
| PFE | PFIZER INC | -5,026,068 | -$133.84M | 0 | 1 | 5 | 5 | 7 |
| VCYT | VERACYTE INC | -4,538,359 | -$155.80M | 0 | 0 | 0 | 2 | 0 |
| ABT | ABBOTT LABORATORIES | -4,368,160 | -$646.53M | 1 | 0 | 4 | 6 | 5 |
| HCA | HCA HEALTHCARE INC | -4,305,414 | -$1.79B | 0 | 1 | 2 | 2 | 4 |
| SYK | STRYKER CORP | -4,239,082 | -$1.65B | 0 | 1 | 4 | 3 | 5 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -4,119,980 | -$813.60M | 0 | 1 | 0 | 2 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | -4,054,089 | -$527.03K | 0 | 0 | 0 | 1 | 0 |
| FMS | FRESENIUS MEDICAL CARE-ADR | -3,890,926 | -$139.48M | 0 | 0 | 1 | 1 | 1 |
| BNTX | BIONTECH SE-ADR | -3,647,091 | -$359.68M | 0 | 0 | 0 | 1 | 0 |
Frequently asked questions about Most sold healthcare stocks in Q4 2025
What are the most sold Healthcare stocks in Q4 2025?
The most sold healthcare stocks in Q4 2025 are those with the largest decrease in reported share counts across tracked institutional investors compared to Q3 2025, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q4 2025?
Among the managers we track, net reductions were largest in companies such as HALEON PLC-ADR (HLN), AVANTOR INC (AVTR), ELANCO ANIMAL HEALTH INC (ELAN), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2025).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.